PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

Well, in doing my DD I learned just a slight bit different in my response today from PharmaCyte than what I read in the email that posted earlier.

All in all, things for me still continue to be positive and moving forward.

xxxx xxxxxxx;

Thank you for your email and for your interest in PharmaCyte Biotech. Yes, this is a reply from PharmaCyte’s investment relations. Don’t confuse both cancer and diabetes however. These are two very different programs, and any funding expected for the company's pancreatic cancer clinical trial is not funding that will also go towards the company’s diabetes program. We thought we made that clear in the response; however, there does seem to be some confusion.

Thank you again for your email and for your interest in PharmaCyte.

Investor Relations
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
O 917.595.2850 | F 917.595.2851 | M 917.595.2856

Go PharmaCyte!
Janssen! Janssen! Janssen!